Reddy Pharma

Dr. Reddy's Laboratories is a leading global pharmaceutical company headquartered in Hyderabad, India, dedicated to providing affordable and innovative medicines. Founded in 1984, the company operates across three primary segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Its extensive portfolio includes over 190 medications and 60 active pharmaceutical ingredients (APIs), spanning therapeutic areas such as oncology, gastroenterology, cardiovascular disease, and dermatology. Dr. Reddy's has a robust presence in major markets including the United States, India, Russia, and Europe, and is increasingly focused on complex generics, biosimilars, and digital health solutions. The company is publicly traded on the NYSE and Indian exchanges, maintaining a strong commitment to research and development through its dedicated research foundation.